Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Tokyo stocks turn lower in thin trading

4h japantimes.co.jp
Stocks fell back on the Tokyo Stock Exchange on Monday, as investors retreated to the sidelines amid a dearth of fresh trading incentives.
ITOCY JAPAF 2914 SFTBF JFEEF TOELY KDDIY SUOPY JAPAY ITOCF 5411 9984 SUMCF KDDIF 8035 TOELF SFTBY

1
British American Tobacco to raise prices in line with October tax hike

6h japantimes.co.jp
British American Tobacco Japan has filed for approval from the Finance Ministry to raise its tobacco product prices in line with the planned tobacco tax hike on Oct. 1, informed sources said Monday.
JAPAF JAPAY 2914 BATS 4162

1
Japan Tobacco seeks approval for price hikes from Finance Ministry

2018-08-14 japantimes.co.jp
Japan Tobacco Inc. on Tuesday filed for Finance Ministry approval over its plans to raise the prices of most of its products in line with the tobacco tax hike set for Oct. 1.
JAPAF JAPAY 2914

10
Turkish lira crash may affect some Japanese companies with operations there

2018-08-14 japantimes.co.jp
Your next vacation in sun-drenched Turkey may now be a lot cheaper. On the flip side, corporate profits from selling goods locally are dwindling by the day when converted to home currencies.
PM JAPAF TM BNPQY DLAKF SCGLF JAPAY AREVA VVCTY HUGPF 7011 VCT MHVYF ITX VOD TAVHF VOD BOSSY SCGLY 2914 TYT BVA BNPQF TOYOF DDAIF TAVHY VLKAF BNPZY VODPF TCG 7203 DLAKY GLE

9
Japan Tobacco to buy Bangladesh firm for $1.5 billion

2018-08-07 japantimes.co.jp
Japan Tobacco Inc. has agreed to buy a Bangladeshi cigarette manufacturer for 124.3 billion taka ($1.5 billion), taking its acquisition strategy to one of Asia’s fastest-growing economies.
PM JAPAF JAPAY 2914

9
Japan Tobacco to Acquire Bangladesh Company for $1.5 Billion - Bloomberg

2018-08-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PM JAPAF JAPAY 2914

3
Deals of the day-Mergers and acquisitions

2018-08-06 reuters
Aug 6 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday:
BAMGF UBNC JAPAF TWX AGODY 2914 AMCRY TWC 532712 PGW FSUGY PGWFY AGO JAPAY RCOM FSUMF ATLGF FMG PGWFF BAMKF KOS BAM

1
Japan Tobacco 2018 Q2 - Results - Earnings Call Slides

2018-08-05 seekingalpha
The following slide deck was published by Japan Tobacco in conjunction with their 2018 Q2 earnings call.
JAPAF JAPAY 2914

1
Japan Tobacco (JAPAF) Q2 2018 Results - Earnings Call Transcript

2018-08-05 seekingalpha
Koji Shimayoshi - Deputy Chief Executive Officer and Executive Vice President Business Development and Corporate Strategy
JAPAF JAPAY 2914

1
Japanese Company Will Keep Greek Tobacco SEKAP Business Going

2018-08-03 thenationalherald
Greek tobacco company SEKAP, which had been in the hands of Russian-Greek businessman Ivan Savvidis, who has had an arrest warrant outstanding against him for almost five months, will keep operating under its new owners, Japan Tobacco International (JTI).
JAPAF JAPAY 2914

6
Opko Health Is A High-Risk And High-Return Stock For 2018

2018-07-20 seekingalpha - 5
The last few months have been good news for Opko Health (OPK) and the company has seen its share prices almost double in this time frame. A mature and growing diagnostics business, early stage pharmaceuticals business with multibillion dollar opportunities, multiple late-stage research programs, and robust implementation of commercial strategy, continue to make this stock an attractive investment proposition for retail investors in 2018.
JAPAF OPK JAPAY 2914

6
Juul e-cigarette expands to England, Scotland, eyes Asia

2018-07-16 cnbc - 1
Starting Tuesday, Juul e-cigarettes will be available in England and Scotland. Juul's first international market was Israel, where it launched in February.
WFC WFCNP IMBBY JAPAF 2914 BATS 4162 ITYBF JAPAY IMBBF

2
Tokyo Smoking Ban Could Shake Up Tobacco, Retail Markets - Bloomberg

2018-06-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JAPAF JAPAY 2914

3
WTO Tobacco Ruling Opens Door to New Plain-Packaging Laws

2018-06-28 theedgemarkets
(June 29): The World Trade Organization upheld Australia’s right to require cigarettes to be sold in plain packs without any logos in a landmark case that could usher in a new wave of global tobacco restrictions.
PM JAPAF JAPAY 2914

3
WTO tobacco ruling opens foor to new plain-packaging laws

2018-06-28 theedgemarkets
GENEVA (June 28): The World Trade Organization upheld Australia’s right to require cigarettes to be sold in plain packs without any logos in a landmark case that could usher in a new wave of global tobacco restrictions.
PM JAPAF JAPAY 2914

Related Articles

REPH: Recro Pharma Analysis and Research Report

10h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

11h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

11h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...